IPO registrations (S-1, F-1) · Registrants
Durata Therapeutics, Inc.
- SEC CIK
- 1544116 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2012-03-22, last 2013-04-09; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2012-07-20; declared effective 2012-07-18
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 200 SOUTH WACKER DRIVE, SUITE 2550, Chicago, IL 60606
- EIN
- 87-1247903
- EDGAR entity type
- operating
- Insiders and CEO pay
- Durata Therapeutics, Inc. on the corporate pages
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 2012-07-09)
- Final price
- $9.00 per share, below the range (424B4 filed 2012-07-20, an initial public offering)
- Shares sold
- 7,500,000
- Gross proceeds
- $67,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol DRTX
- Lead underwriters
- Merrill Lynch; Credit Suisse
- Syndicate
- BofA Securities; RBC Capital Markets; Wedbush Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: DURATA THERAPEUTICS, INC. Fuzzy (name and state)
- SEC filer: Durata Therapeutics, Inc. EXACT (CIK (EXACT))
- Person page: Lisa M Giles Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-03-22 | S-1 | S-1 (registration) | Durata Therapeutics, Inc. | 0001193125-12-127352 ↗ |
| 2012-04-30 | S-1/A | S-1/A (amendment) | Durata Therapeutics, Inc. | 0001193125-12-196282 ↗ |
| 2012-05-18 | S-1/A | S-1/A (amendment) | Durata Therapeutics, Inc. | 0001193125-12-239393 ↗ |
| 2012-06-22 | S-1/A | S-1/A (amendment) | Durata Therapeutics, Inc. | 0001193125-12-280109 ↗ |
| 2012-07-09 | S-1/A | S-1/A (amendment) | Durata Therapeutics, Inc. | 0001193125-12-297518 ↗ |
| 2012-07-18 | EFFECT | EFFECT (declared effective) | Durata Therapeutics, Inc. | 9999999995-12-002192 ↗ |
| 2012-07-20 | 424B4 | 424B4 (final prospectus) | Durata Therapeutics, Inc. | 0001193125-12-307785 ↗ |
| 2013-03-29 | S-1 | S-1 (registration) | Durata Therapeutics, Inc. | 0001193125-13-134592 ↗ |
| 2013-04-09 | S-1/A | S-1/A (amendment) | Durata Therapeutics, Inc. | 0001193125-13-147627 ↗ |
| 2013-04-11 | EFFECT | EFFECT (declared effective) | Durata Therapeutics, Inc. | 9999999995-13-000972 ↗ |
| 2013-04-12 | 424B4 | 424B4 (final prospectus) | Durata Therapeutics, Inc. | 0001193125-13-153028 ↗ |
| 2014-04-24 | EFFECT | EFFECT (declared effective) | Durata Therapeutics, Inc. | 9999999995-14-001114 ↗ |
| 2014-11-18 | EFFECT | EFFECT (declared effective) | Durata Therapeutics, Inc. | 9999999995-14-003442 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-07-09 | S-1/A | registration statement | $11.00–$13.00 | 6,250,000 | - | Nasdaq DRTX | 5 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2012-07-20 | 424B4 | final prospectus | $9.00 | 7,500,000 | $67,500,000 | Nasdaq DRTX | 5 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Ahrens Brenton Karl | Director; Director,TenPercentOwner | 5 | 2012–2014 | ||
| AISLING CAPITAL III LP | TenPercentOwner | 4 | 2012–2014 | ||
| Aisling Capital Partners III LLC | TenPercentOwner | 4 | 2012–2014 | ||
| Aisling Capital Partners III LP | TenPercentOwner | 4 | 2012–2014 | ||
| AKKARAJU SRINIVAS | TenPercentOwner | 2 | 2012 | ||
| Allen Susan Roberta | TenPercentOwner | 1 | 2012 | ||
| Birchler Angela Gurski | TenPercentOwner | 1 | 2012 | ||
| BLAIR JAMES C | TenPercentOwner | 5 | 2012–2014 | ||
| Canaan Partners VIII LLC | Director; Director,TenPercentOwner | 7 | 2012–2014 | ||
| Canaan VIII LP | Director; Director,TenPercentOwner | 8 | 2012–2014 | ||
| Chambon Philippe O. | TenPercentOwner | 3 | 2012–2014 | ||
| Delagardelle Jeani | TenPercentOwner | 3 | 2012–2014 | ||
| DE SCHUTTER RICHARD U | Director; Director,TenPercentOwner | 7 | 2012–2014 | ||
| DOMAIN ASSOCIATES | TenPercentOwner | 2 | 2012–2014 | ||
| Domain Partners VIII, L.P. | TenPercentOwner | 3 | 2012–2014 | ||
| DOVEY BRIAN H | TenPercentOwner | 5 | 2012–2014 | ||
| DP VIII Associates, L.P. | TenPercentOwner | 3 | 2012–2014 | ||
| Dunne Michael W. | Officer; Officer,TenPercentOwner | Chief Medical Officer | 6 | 2012–2014 | |
| Edick Paul R | Director,Officer; Director,Officer,TenPercentOwner | CEO and President; Chief Executive Officer | 9 | 2012–2014 | |
| ELMS STEVE | TenPercentOwner | 4 | 2012–2014 | ||
| Fishman Corey N. | Officer; Officer,TenPercentOwner | CFO & COO; CFO&COO; COO & CFO; COO, Secretary & Treasurer | 6 | 2012–2014 | |
| GOLDSTEIN DOV A MD | Director,TenPercentOwner | 2 | 2012 | ||
| Halak Brian K | TenPercentOwner | 5 | 2012–2014 | ||
| HORNER GEORGE F III | Director; Director,TenPercentOwner | 2 | 2012 | ||
| HUNT RONALD | Director,TenPercentOwner | 4 | 2012–2014 | ||
| Kamdar Kim P. | TenPercentOwner | 2 | 2012–2014 | ||
| Kovacevic Milan | TenPercentOwner | 1 | 2012 | ||
| Lack Jeremy David | TenPercentOwner | 1 | 2012 | ||
| Lathi Vijay K | TenPercentOwner | 3 | 2012–2014 | ||
| New Leaf Venture Associates II, L.P. | TenPercentOwner | 3 | 2012–2014 | ||
| New Leaf Venture Management II, L.L.C. | TenPercentOwner | 3 | 2012–2014 | ||
| New Leaf Ventures II, L.P. | TenPercentOwner | 3 | 2012–2014 | ||
| NIEDEL JAMES | TenPercentOwner | 2 | 2012 | ||
| OBOYLE KEVIN C | Director | 5 | 2012–2014 | ||
| Pe Benjamin Manlaui | Other; TenPercentOwner | 2 | 2012–2013 | ||
| Purcell Dennis J | TenPercentOwner | 4 | 2012–2014 | ||
| SCHIFF ANDREW N | TenPercentOwner | 4 | 2012–2014 | ||
| SCHOEMAKER KATHLEEN K | TenPercentOwner | 5 | 2012–2014 | ||
| Shannon John Patrick Jr | Officer | Chief Commercial Officer | 6 | 2012–2014 | |
| Talbot George Harrison | TenPercentOwner | 1 | 2012 | ||
| TREU JESSE I | TenPercentOwner | 5 | 2012–2014 | ||
| Trust Ronald Irving | Other; TenPercentOwner | 2 | 2012–2013 | ||
| VITULLO NICOLE | Director,TenPercentOwner | 7 | 2012–2014 | ||
| HEALY JAMES | Director,TenPercentOwner | 2 | 2012 | ||
| Sofinnova Management VII, L.L.C. | TenPercentOwner | 2 | 2012 | ||
| SOFINNOVA VENTURE PARTNERS VII L P | TenPercentOwner | 2 | 2012 | ||
| Buatois Eric | TenPercentOwner | 1 | 2012 | ||
| POWELL MICHAEL | TenPercentOwner | 1 | 2012 | ||
| Canaan Management, Inc. | Director | 5 | 2012–2014 | ||
| Giles Lisa M. | Director | 8 | 2013–2014 | person page Fuzzy | |
| FRIEDMAN PAUL A | Director | 4 | 2013–2014 | ||
| CARROLL J MARTIN | Director | 3 | 2014 | ||
| YARNO WENDY L | Director | 3 | 2014 | ||
| Ratcliffe Liam | TenPercentOwner | 1 | 2014 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | DURATA THERAPEUTICS, INC. | IL | State business registries | name and state |
| SEC filer | Durata Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Lisa M Giles | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, IL first:
- APP Pharmaceuticals, Inc. IL
- XERIS PHARMACEUTICALS INC IL
- Sagent Pharmaceuticals, Inc. IL
- Wellness Center USA, Inc. IL
- AbbVie Inc. IL
- PharMEDium Healthcare Holdings, Inc. IL
- Baxalta Inc IL
- Accelerated Pharma, Inc. IL
- Monopar Therapeutics IL
- Aptinyx Inc. IL
In other datasets, the same topic (Health) in IL:
- Nonprofit: 5 LOAVES 2 FISHES FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health